GO:0060795 | cell fate commitment involved in formation of primary germ layer | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0023057 | negative regulation of signaling | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0097242 | beta-amyloid clearance | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0072376 | protein activation cascade | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0042954 | lipoprotein transporter activity | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0051435 | BH4 domain binding | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0032370 | positive regulation of lipid transport | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0006464 | cellular protein modification process | 6.91e-04 | 1.00e+00 | 5.616 | 2 | 4 | 84 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0032429 | regulation of phospholipase A2 activity | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0060279 | positive regulation of ovulation | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0070325 | lipoprotein particle receptor binding | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0038127 | ERBB signaling pathway | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0032374 | regulation of cholesterol transport | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0051222 | positive regulation of protein transport | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0005515 | protein binding | 2.21e-03 | 1.00e+00 | 1.260 | 7 | 198 | 6024 |
GO:0031012 | extracellular matrix | 2.30e-03 | 1.00e+00 | 4.742 | 2 | 6 | 154 |
GO:0001714 | endodermal cell fate specification | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0014909 | smooth muscle cell migration | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0031639 | plasminogen activation | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 1 | 7 |
GO:0007172 | signal complex assembly | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0060396 | growth hormone receptor signaling pathway | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0031953 | negative regulation of protein autophosphorylation | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 10 |
GO:0014912 | negative regulation of smooth muscle cell migration | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 11 |
GO:0017166 | vinculin binding | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 11 |
GO:0010875 | positive regulation of cholesterol efflux | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 4 | 11 |
GO:0035909 | aorta morphogenesis | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0042953 | lipoprotein transport | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 2 | 12 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 13 |
GO:0043277 | apoptotic cell clearance | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 13 |
GO:0034614 | cellular response to reactive oxygen species | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 2 | 14 |
GO:0034185 | apolipoprotein binding | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 14 |
GO:0001824 | blastocyst development | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 2 | 15 |
GO:0043274 | phospholipase binding | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 16 |
GO:0042730 | fibrinolysis | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 3 | 18 |
GO:0045861 | negative regulation of proteolysis | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 4 | 18 |
GO:0019901 | protein kinase binding | 9.40e-03 | 1.00e+00 | 3.700 | 2 | 18 | 317 |
GO:0071549 | cellular response to dexamethasone stimulus | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 3 | 20 |
GO:0008283 | cell proliferation | 1.00e-02 | 1.00e+00 | 3.651 | 2 | 14 | 328 |
GO:0048041 | focal adhesion assembly | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 1 | 21 |
GO:0044822 | poly(A) RNA binding | 1.10e-02 | 1.00e+00 | 2.549 | 3 | 50 | 1056 |
GO:0005925 | focal adhesion | 1.24e-02 | 1.00e+00 | 3.493 | 2 | 9 | 366 |
GO:0035987 | endodermal cell differentiation | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 26 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 2 | 27 |
GO:0048754 | branching morphogenesis of an epithelial tube | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 27 |
GO:0006508 | proteolysis | 1.32e-02 | 1.00e+00 | 3.446 | 2 | 6 | 378 |
GO:0005875 | microtubule associated complex | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 1 | 28 |
GO:0030032 | lamellipodium assembly | 1.40e-02 | 1.00e+00 | 6.151 | 1 | 1 | 29 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 30 |
GO:0048167 | regulation of synaptic plasticity | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 2 | 30 |
GO:0035249 | synaptic transmission, glutamatergic | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 3 | 32 |
GO:0005737 | cytoplasm | 1.56e-02 | 1.00e+00 | 1.451 | 5 | 124 | 3767 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.60e-02 | 1.00e+00 | 3.298 | 2 | 30 | 419 |
GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway | 1.69e-02 | 1.00e+00 | 5.879 | 1 | 2 | 35 |
GO:0030178 | negative regulation of Wnt signaling pathway | 1.69e-02 | 1.00e+00 | 5.879 | 1 | 4 | 35 |
GO:0042157 | lipoprotein metabolic process | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 36 |
GO:0034446 | substrate adhesion-dependent cell spreading | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 36 |
GO:0008047 | enzyme activator activity | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 3 | 39 |
GO:0035019 | somatic stem cell maintenance | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 6 | 40 |
GO:0030136 | clathrin-coated vesicle | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 5 | 42 |
GO:0031124 | mRNA 3'-end processing | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 2 | 42 |
GO:0051591 | response to cAMP | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 4 | 45 |
GO:0043434 | response to peptide hormone | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 5 | 45 |
GO:0006369 | termination of RNA polymerase II transcription | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 2 | 45 |
GO:0001523 | retinoid metabolic process | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 1 | 48 |
GO:0005905 | coated pit | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 6 | 50 |
GO:0051028 | mRNA transport | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 4 | 52 |
GO:0009611 | response to wounding | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 5 | 52 |
GO:0005509 | calcium ion binding | 2.51e-02 | 1.00e+00 | 2.956 | 2 | 11 | 531 |
GO:0030666 | endocytic vesicle membrane | 2.54e-02 | 1.00e+00 | 5.281 | 1 | 1 | 53 |
GO:0001725 | stress fiber | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 4 | 55 |
GO:0008203 | cholesterol metabolic process | 2.73e-02 | 1.00e+00 | 5.176 | 1 | 2 | 57 |
GO:0005643 | nuclear pore | 2.73e-02 | 1.00e+00 | 5.176 | 1 | 11 | 57 |
GO:0008013 | beta-catenin binding | 2.88e-02 | 1.00e+00 | 5.102 | 1 | 9 | 60 |
GO:0006406 | mRNA export from nucleus | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 4 | 61 |
GO:0043085 | positive regulation of catalytic activity | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 2 | 61 |
GO:0019903 | protein phosphatase binding | 2.97e-02 | 1.00e+00 | 5.055 | 1 | 2 | 62 |
GO:0030141 | secretory granule | 2.97e-02 | 1.00e+00 | 5.055 | 1 | 4 | 62 |
GO:0030574 | collagen catabolic process | 3.21e-02 | 1.00e+00 | 4.943 | 1 | 2 | 67 |
GO:0010468 | regulation of gene expression | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 2 | 68 |
GO:0034329 | cell junction assembly | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 3 | 68 |
GO:0032355 | response to estradiol | 3.40e-02 | 1.00e+00 | 4.859 | 1 | 3 | 71 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 3.54e-02 | 1.00e+00 | 4.799 | 1 | 4 | 74 |
GO:0002020 | protease binding | 3.54e-02 | 1.00e+00 | 4.799 | 1 | 6 | 74 |
GO:0004222 | metalloendopeptidase activity | 3.68e-02 | 1.00e+00 | 4.742 | 1 | 1 | 77 |
GO:0007603 | phototransduction, visible light | 3.73e-02 | 1.00e+00 | 4.723 | 1 | 1 | 78 |
GO:0007229 | integrin-mediated signaling pathway | 3.73e-02 | 1.00e+00 | 4.723 | 1 | 3 | 78 |
GO:0045177 | apical part of cell | 3.87e-02 | 1.00e+00 | 4.669 | 1 | 3 | 81 |
GO:0009653 | anatomical structure morphogenesis | 3.96e-02 | 1.00e+00 | 4.634 | 1 | 2 | 83 |
GO:0006898 | receptor-mediated endocytosis | 4.01e-02 | 1.00e+00 | 4.616 | 1 | 3 | 84 |
GO:0006936 | muscle contraction | 4.15e-02 | 1.00e+00 | 4.566 | 1 | 3 | 87 |
GO:0000187 | activation of MAPK activity | 4.29e-02 | 1.00e+00 | 4.517 | 1 | 3 | 90 |
GO:0007010 | cytoskeleton organization | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 4 | 91 |
GO:0006928 | cellular component movement | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 3 | 91 |
GO:0005178 | integrin binding | 4.57e-02 | 1.00e+00 | 4.424 | 1 | 4 | 96 |
GO:0043235 | receptor complex | 4.71e-02 | 1.00e+00 | 4.379 | 1 | 2 | 99 |
GO:0008360 | regulation of cell shape | 4.89e-02 | 1.00e+00 | 4.322 | 1 | 4 | 103 |
GO:0005938 | cell cortex | 4.94e-02 | 1.00e+00 | 4.308 | 1 | 5 | 104 |
GO:0004252 | serine-type endopeptidase activity | 5.03e-02 | 1.00e+00 | 4.281 | 1 | 3 | 106 |
GO:0022617 | extracellular matrix disassembly | 5.08e-02 | 1.00e+00 | 4.267 | 1 | 2 | 107 |
GO:0030529 | ribonucleoprotein complex | 5.31e-02 | 1.00e+00 | 4.201 | 1 | 5 | 112 |
GO:0043524 | negative regulation of neuron apoptotic process | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 5 | 117 |
GO:0007568 | aging | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 2 | 117 |
GO:0030027 | lamellipodium | 5.91e-02 | 1.00e+00 | 4.043 | 1 | 7 | 125 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 6.05e-02 | 1.00e+00 | 4.009 | 1 | 11 | 128 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 6.23e-02 | 1.00e+00 | 3.964 | 1 | 4 | 132 |
GO:0045202 | synapse | 6.42e-02 | 1.00e+00 | 3.921 | 1 | 5 | 136 |
GO:0005887 | integral component of plasma membrane | 6.47e-02 | 1.00e+00 | 2.214 | 2 | 10 | 888 |
GO:0001666 | response to hypoxia | 7.01e-02 | 1.00e+00 | 3.790 | 1 | 7 | 149 |
GO:0000398 | mRNA splicing, via spliceosome | 7.69e-02 | 1.00e+00 | 3.651 | 1 | 15 | 164 |
GO:0044212 | transcription regulatory region DNA binding | 7.88e-02 | 1.00e+00 | 3.616 | 1 | 17 | 168 |
GO:0005768 | endosome | 7.92e-02 | 1.00e+00 | 3.608 | 1 | 3 | 169 |
GO:0008270 | zinc ion binding | 7.95e-02 | 1.00e+00 | 2.047 | 2 | 27 | 997 |
GO:0016607 | nuclear speck | 8.06e-02 | 1.00e+00 | 3.582 | 1 | 12 | 172 |
GO:0005667 | transcription factor complex | 8.19e-02 | 1.00e+00 | 3.558 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 8.33e-02 | 1.00e+00 | 3.533 | 1 | 5 | 178 |
GO:0032403 | protein complex binding | 8.55e-02 | 1.00e+00 | 3.493 | 1 | 6 | 183 |
GO:0004872 | receptor activity | 8.82e-02 | 1.00e+00 | 3.446 | 1 | 8 | 189 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 8.82e-02 | 1.00e+00 | 3.446 | 1 | 5 | 189 |
GO:0005654 | nucleoplasm | 9.17e-02 | 1.00e+00 | 1.929 | 2 | 64 | 1082 |
GO:0005765 | lysosomal membrane | 9.45e-02 | 1.00e+00 | 3.343 | 1 | 3 | 203 |
GO:0030425 | dendrite | 1.06e-01 | 1.00e+00 | 3.163 | 1 | 6 | 230 |
GO:0008380 | RNA splicing | 1.06e-01 | 1.00e+00 | 3.176 | 1 | 22 | 228 |
GO:0008134 | transcription factor binding | 1.12e-01 | 1.00e+00 | 3.090 | 1 | 18 | 242 |
GO:0043025 | neuronal cell body | 1.13e-01 | 1.00e+00 | 3.072 | 1 | 9 | 245 |
GO:0005886 | plasma membrane | 1.14e-01 | 1.00e+00 | 1.259 | 3 | 49 | 2582 |
GO:0000166 | nucleotide binding | 1.19e-01 | 1.00e+00 | 2.992 | 1 | 13 | 259 |
GO:0030198 | extracellular matrix organization | 1.30e-01 | 1.00e+00 | 2.864 | 1 | 6 | 283 |
GO:0005856 | cytoskeleton | 1.33e-01 | 1.00e+00 | 2.824 | 1 | 9 | 291 |
GO:0005634 | nucleus | 1.48e-01 | 1.00e+00 | 0.854 | 4 | 159 | 4559 |
GO:0015031 | protein transport | 1.54e-01 | 1.00e+00 | 2.595 | 1 | 11 | 341 |
GO:0003723 | RNA binding | 1.55e-01 | 1.00e+00 | 2.591 | 1 | 18 | 342 |
GO:0043565 | sequence-specific DNA binding | 1.56e-01 | 1.00e+00 | 2.574 | 1 | 11 | 346 |
GO:0007155 | cell adhesion | 1.66e-01 | 1.00e+00 | 2.481 | 1 | 5 | 369 |
GO:0009986 | cell surface | 1.80e-01 | 1.00e+00 | 2.358 | 1 | 9 | 402 |
GO:0007596 | blood coagulation | 2.01e-01 | 1.00e+00 | 2.179 | 1 | 11 | 455 |
GO:0048471 | perinuclear region of cytoplasm | 2.20e-01 | 1.00e+00 | 2.037 | 1 | 8 | 502 |
GO:0010467 | gene expression | 2.83e-01 | 1.00e+00 | 1.623 | 1 | 45 | 669 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.94e-01 | 1.00e+00 | 1.560 | 1 | 39 | 699 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.26e-01 | 1.00e+00 | 1.385 | 1 | 41 | 789 |
GO:0070062 | extracellular vesicular exosome | 3.29e-01 | 1.00e+00 | 0.780 | 2 | 57 | 2400 |
GO:0007165 | signal transduction | 3.65e-01 | 1.00e+00 | 1.184 | 1 | 13 | 907 |
GO:0005576 | extracellular region | 3.77e-01 | 1.00e+00 | 1.129 | 1 | 13 | 942 |
GO:0005615 | extracellular space | 3.82e-01 | 1.00e+00 | 1.106 | 1 | 20 | 957 |
GO:0006355 | regulation of transcription, DNA-templated | 3.94e-01 | 1.00e+00 | 1.047 | 1 | 43 | 997 |
GO:0003677 | DNA binding | 4.61e-01 | 1.00e+00 | 0.758 | 1 | 49 | 1218 |
GO:0005730 | nucleolus | 5.71e-01 | 1.00e+00 | 0.328 | 1 | 66 | 1641 |
GO:0016020 | membrane | 5.80e-01 | 1.00e+00 | 0.294 | 1 | 46 | 1681 |
GO:0005829 | cytosol | 7.36e-01 | 1.00e+00 | -0.277 | 1 | 86 | 2496 |